生物科技(BK1161)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BK1161 生物科技

休市中 03-06 16:00:00

5,500.107

+216.878

+4.11%

最高5,548.282	最低5,244.833	成交量2.52亿
今开5,283.774	昨收5,283.230	日振幅5.74%
总市值0.00	流通市值0.00	总股本0.00
成交额97.81亿	换手率--	流通股本0.00
市净率7.188813	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"BK1161","market":"HK","secType":"PLATE","nameCN":"生物科技","latestPrice":5500.1074,"timestamp":1772784497227,"preClose":5283.2295,"halted":0,"volume":251700571,"delay":0,"changeRate":0.04105,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":216.87793,"latestTime":"03-06 16:00:00","open":5283.774,"high":5548.2817,"low":5244.8325,"amount":9781290815.27,"amplitude":0.057436,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773019800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1772760600000,1772769600000],[1772773200000,1772784000000]],"pbRate":7.188813,"peRate":-91.479903,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK1161","defaultTab":"news","newsList":[{"id":"2617565490","title":"两会｜政府工作报告13次提及“保险”，是何用意？最新解读来了","url":"https://stock-news.laohu8.com/highlight/detail?id=2617565490","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617565490?lang=zh_cn&edition=full","pubTime":"2026-03-07 09:16","pubTimestamp":1772846160,"startTime":"0","endTime":"0","summary":"加快发展商业健康保险今年政府工作报告提出，更大力度保障和改善民生。去年政府工作报告曾提到“制定创新药目录”，今年在总结2025年工作时提及“推出商业健康保险创新药目录”。众惠相互保险相关负责人表示，政府工作报告提出“加快发展商业健康保险”，释放出定位升级、功能扩容、协同深化的强烈政策信号。长期护理保险制度已多次写入政府工作报告。政府工作报告持续将之列入是积极回应社会需求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA3NjM5MjIwOQ==&mid=2652257466&idx=3&sn=0517a4849b3e8cdee3705fc2cf81977a&chksm=85ed0477dd3625cdc40d6936315dbf11a554f5e4d4f0881d35a56f761e08357925dd4db78300&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["06978","BK4585","BK4588","BK1574","BK1161","LABU","XBI","BK4581","XLV"],"gpt_icon":0},{"id":"2617665530","title":"【ETF动向】3月6日广发中证创新药产业ETF基金涨3.09%，份额减少6200万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2617665530","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617665530?lang=zh_cn&edition=full","pubTime":"2026-03-07 06:31","pubTimestamp":1772836291,"startTime":"0","endTime":"0","summary":"证券之星消息，3月6日，广发中证创新药产业ETF基金（515120）涨3.09%，成交额3.21亿元。当日份额减少了6200万份，最新份额为142.52亿份，近20个交易日份额增加1.41亿份。当日资金净流入2.12亿元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为85.48亿元。广发中证创新药产业ETF基金跟踪标的为中证创新药产业指数，成立（2020-12-03）以来超额回报为-1.74%，近一个月超额回报为-0.03%，管理人为广发基金公司，基金经理为罗国庆。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030700003161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1574","06978","159992"],"gpt_icon":0},{"id":"2617663094","title":"从零到40亿美元的中国创新药奇迹","url":"https://stock-news.laohu8.com/highlight/detail?id=2617663094","media":"中国经营网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617663094?lang=zh_cn&edition=full","pubTime":"2026-03-07 04:23","pubTimestamp":1772828611,"startTime":"0","endTime":"0","summary":"“从财务角度来看，我们兑现了所有承诺，实现了产品收入显著增长、美国公认会计原则（GAAP）盈利以及可观的现金流。”近日，百济神州（688235.SH、6160.HK、ONC.O）总裁兼首席运营官吴晓滨在电话会议上如此表示。根据业绩快报，百济神州2025年首次实现年度盈利，营收同比增长40.4%至约382.05亿元，净利润约14.22亿元。报告期内，公司产品收入377.7亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603073664866394.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK1161","06978","159992"],"gpt_icon":0},{"id":"2617635561","title":"顶尖药企竞相推出减重口服药","url":"https://stock-news.laohu8.com/highlight/detail?id=2617635561","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617635561?lang=zh_cn&edition=full","pubTime":"2026-03-06 22:16","pubTimestamp":1772806560,"startTime":"0","endTime":"0","summary":"全球减重药物市场正进入新阶段，推动因素包括口服剂型上市、仿制药竞品即将到来，以及礼来、诺和诺德旗下重磅产品在美国降价。　　这一快速变化的格局，促使华尔街重新审视未来十年减重药市场规模将达 1500 亿美元的长期预测。　　诺和诺德成为首家推出口服 GLP1 减重药的企业，这家丹麦药企在快速演变的减重治疗市场中获得了竞争优势。　　中国歌礼制药的在研口服 GLP1 药物ASC30，在美国二期临床试验中最高减重7.7%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-03-06/doc-inhqanka2342553.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0306807586.USD","VKTX","LU1057294990.SGD","BK4588","BK4533","MRK","000963","01801","SG9999001176.SGD","LU2097828474.EUR","HK0000165453.HKD","BK4581","LU0170899867.USD","LU0321505439.SGD","LU1883839398.USD","LU2488822045.USD","LU1066053197.SGD","LU2097828631.EUR","LU0456855351.SGD","LU0234572021.USD","LLY","LU0225284248.USD","IE00B19Z3581.USD","SG9999011175.SGD","SG9999002232.USD","BK4568","IE00BLSP4452.SGD","LU0868494617.USD","LU1066051498.USD","LU2097828714.EUR","RHHBY","PFE","BK1161","LU2097828805.USD","BK1589","LU1969619763.USD","BK4534","LU0306806265.USD","LU0122379950.USD","IE00BLSP4239.USD","BK4585","LU1894683348.USD","LU1023059063.AUD","LU2097828557.USD","BK4599","SG9999013999.USD","NVO","BK4550","LU2242644610.SGD","LU0985481810.HKD","LU0502904849.HKD","LU0321505868.SGD","SGXZ57979304.SGD","SG9999002224.SGD","LU0455707207.USD","LU0225771236.USD","IE00B19Z3B42.SGD","BK4592","AZN","IE00BBT3K403.USD","BK1583","LU0058720904.USD","LU2328871848.SGD","BK4007","SG9999003800.SGD","LU0289739699.SGD","SG9999001176.USD","IE0002270589.USD","LU1894683264.USD","IE000M9KFDE8.USD"],"gpt_icon":1},{"id":"1136865495","title":"科济药业-B预期2026年末现金及等价物不低于10亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1136865495","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136865495?lang=zh_cn&edition=full","pubTime":"2026-03-06 20:10","pubTimestamp":1772799016,"startTime":"0","endTime":"0","summary":"科济药业-B（股票代码：02171）近日披露，公司预计至2026年12月31日，其现金及现金等价物余额将维持在至少人民币10亿元的水平。这一财务预期反映了公司在资金管理方面的稳健策略，同时也为其未来在细胞治疗领域的研发投入和业务拓展提供了坚实的财务支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1587","BK1585","02171","BK1574"],"gpt_icon":0},{"id":"2617687533","title":"科济药业-B(02171)发布2025年度业绩，股东应占亏损9786.1万元，同比收窄87.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617687533","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617687533?lang=zh_cn&edition=full","pubTime":"2026-03-06 20:06","pubTimestamp":1772798807,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科济药业-B(02171)发布截至2025年12月31日止年度业绩，收益1.26亿元(人民币，下同)，同比增长218.7%;母公司拥有人应占亏损9786.1万元，同比收窄87.7%;每股基本亏损0.18元。截至2025年12月31日止年度，集团的收益主要来自赛恺泽® (自体BCMA CAR-T细胞产品)，其中赛恺泽®的主要收益乃以出厂价格而非终端市场价进行计算的。集团的收益于完成产品的出厂交付后确认。由于CAR-T生产存在必需的时间周期，从华东医药获得的订单数量与出厂交付的数量存在差异。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411158.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02171","BK1585","BK1574","BK1587"],"gpt_icon":0},{"id":"2617092687","title":"三大指数集体收涨，题材轮动加快，创新药、农业板块强势反弹 | 华宝3A日报（2026.3.6）","url":"https://stock-news.laohu8.com/highlight/detail?id=2617092687","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617092687?lang=zh_cn&edition=full","pubTime":"2026-03-06 20:06","pubTimestamp":1772798760,"startTime":"0","endTime":"0","summary":"三大指数集体收涨，题材轮动加快，创新药、农业板块强势反弹 | 华宝3A日报（2026.3.6）\n\n\nMACD金叉信号形成，这些股涨势不错！\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：刘万里 SF014","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-03-06/doc-inhqahai5844828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","06978","BK1574","159992"],"gpt_icon":0},{"id":"2617686027","title":"昊海生物科技(06826)注销58.07万股已回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2617686027","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617686027?lang=zh_cn&edition=full","pubTime":"2026-03-06 17:42","pubTimestamp":1772790164,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，于2025年12月5日至2025年12月29日期间购回的58.07万股H股股份已于2026年3月6日于香港注销。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411031.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","BK1161","06826"],"gpt_icon":0},{"id":"2617860476","title":"AI技术推动医药领域创新“加速跑”","url":"https://stock-news.laohu8.com/highlight/detail?id=2617860476","media":"经济参考网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617860476?lang=zh_cn&edition=full","pubTime":"2026-03-06 17:27","pubTimestamp":1772789231,"startTime":"0","endTime":"0","summary":"AI成为2026年两会关注的热点，而随着AI技术的加速创新和应用，医药领域的新药研发也开启了“加速跑”。从底层技术突破到临床验证，一个由数据驱动、智能设计的医药研发新范式加速成型。近日，国内AI蛋白质设计公司分子之心，宣布其AI蛋白质优化与设计平台MoleculeOS完成重大升级，在抗体设计、酶改造等关键任务中达到解决实际产业难题的精度。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603063664572449.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","09939","BK1574","BK1161","159938"],"gpt_icon":0},{"id":"2617068639","title":"百济神州(06160)授出合共2.12万股美国存托股份受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2617068639","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617068639?lang=zh_cn&edition=full","pubTime":"2026-03-06 17:20","pubTimestamp":1772788807,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布公告，于2026年3月2日，董事会薪酬委员会根据2016期权及激励计划的条款授予180名承授人合共2.12万股美国存托股份受限制股份单位。该等受限制股份单位相当于27.56万股股份，约占本公告的日公司发行股份总数的0.02%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","BK0239","BK1500","06160","LU1770034418.SGD","LU0588546209.SGD","BK1588","LU1303224171.USD","BK4526","LU1969619763.USD","LU2328871848.SGD","ONC","688235","BK1583","LU1719994722.HKD","BK1161","LU1251922891.USD","BK4585","LU0307460666.USD","BK4588"],"gpt_icon":0},{"id":"2617857206","title":"维立志博-B(09887)获纳入恒生综合指数成份股及获调入港股通股票名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2617857206","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617857206?lang=zh_cn&edition=full","pubTime":"2026-03-06 17:15","pubTimestamp":1772788549,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维立志博-B(09887)发布公告，自2026年3月9日起，公司股份将获恒生指数有限公司纳入恒生综合指数成份股及获调入港股通标的名单。股份获纳入恒生综合指数及港股通标的证券是资本市场对公司表现及价值的高度认可，并允许中国内地合资格投资者透过沪港通及深港通机制直接投资于香港联合交易所有限公司上市的股份。预期纳入将进一步扩大公司的投资者基础，提升股份的交易流动性，并进一步优化股东结构。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411007.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","VXUS","HK0000252160.HKD","HK0000500386.USD","09887","HK0000252152.HKD","HSCI","BK4585","BK4588","VT"],"gpt_icon":0},{"id":"2617685492","title":"派格生物医药-B(02565)：派格生物新一代GLP-1(CR059)首次人体试验取得一个月临床观察结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2617685492","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617685492?lang=zh_cn&edition=full","pubTime":"2026-03-06 17:04","pubTimestamp":1772787852,"startTime":"0","endTime":"0","summary":"派格生物医药-B(02565)发布公告，公司基于环状RNA(CircRNA)蛋白替代技术并结合人工智能辅助分子设计平台自主研发的新一代GLP-1受体激动剂CR059，为PB-2309三受体(GLP-1/GIP/GCG)激动剂项目分阶段开发策略中针对GLP-1受体激动机制进行先行临床验证的候选产品，已于受试者中完成单次给药并取得一个月人体临床观察结果。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_48.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_48.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410994.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","BK4144","02565","GLP","161726","BK4588","BK4585","BK4590","399441","LABU"],"gpt_icon":0},{"id":"2617683670","title":"维立志博-B(09887)：维利信™于一线食管鳞状细胞癌II期试验的首例患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2617683670","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617683670?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:33","pubTimestamp":1772786017,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维立志博-B(09887)发布公告，评价维利信™(PD-L1/4-1BB双特异性抗体奥帕替苏米单抗，LBL-024)用于治疗一线食管鳞状细胞癌的II期临床研究首例患者已成功入组。本次开展的开放标签、多中心Ⅱ期临床研究由北京大学肿瘤医院沈琳院长牵头，正在全国多家医院同步推进。该试验旨在评价奥帕替苏米单抗用于治疗一线食管鳞状细胞癌患者的有效性和安全性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410955.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000252152.HKD","HK0000252160.HKD","HK0000500386.USD","09887","BK1161"],"gpt_icon":0},{"id":"2617652082","title":"每日卖空追踪 | 诺诚健华 03月06日卖空量成交17.9万股，卖空比例为2.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617652082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617652082?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:30","pubTimestamp":1772785842,"startTime":"0","endTime":"0","summary":"诺诚健华北京时间03月06日，涨5.44%，卖空量成交17.9万股，较上一交易日减少69.87%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163623a4535eda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163623a4535eda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","09969"],"gpt_icon":0},{"id":"2617065459","title":"每日卖空追踪 | 康宁杰瑞制药-B 03月06日卖空量成交1.4万股，卖空比例为1.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617065459","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617065459?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:30","pubTimestamp":1772785842,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B北京时间03月06日，涨0.77%，卖空量成交1.4万股，较上一交易日减少46.15%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163627a4535ef1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163627a4535ef1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09966","BK1161"],"gpt_icon":0},{"id":"2617387566","title":"每日卖空追踪 | 荃信生物-B 03月06日卖空量成交2800股，卖空比例为3.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617387566","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617387566?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:30","pubTimestamp":1772785831,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间03月06日，涨3.7%，卖空量成交2800股，较上一交易日增加100%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163421a6aa3e44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163421a6aa3e44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2617378651","title":"每日卖空追踪 | 乐普生物-B 03月06日卖空量成交45万股，卖空比例为4.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617378651","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617378651?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:30","pubTimestamp":1772785827,"startTime":"0","endTime":"0","summary":"乐普生物-B北京时间03月06日，涨5.28%，卖空量成交45万股，较上一交易日减少41.79%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163328a6aa3d24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163328a6aa3d24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2617656650","title":"每日卖空追踪 | 信达生物 03月06日卖空量成交119.5万股，卖空比例为9.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617656650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617656650?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:30","pubTimestamp":1772785824,"startTime":"0","endTime":"0","summary":"信达生物北京时间03月06日，涨6.18%，卖空量成交119.5万股，较上一交易日减少53.49%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163300a6aa3c7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163300a6aa3c7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0502904849.HKD","LU2097828714.EUR","BK1589","LU2097828805.USD","BK1583","LU2097828474.EUR","LU0455707207.USD","01801","LU2242644610.SGD","LU2097828631.EUR","LU2488822045.USD","LU2328871848.SGD","LU2097828557.USD","HK0000165453.HKD","LU1969619763.USD"],"gpt_icon":0},{"id":"2617819146","title":"每日卖空追踪 | 三生制药 03月06日卖空量成交158.35万股，卖空比例为3.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617819146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617819146?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:30","pubTimestamp":1772785822,"startTime":"0","endTime":"0","summary":"三生制药北京时间03月06日，涨9.42%，卖空量成交158.35万股，较上一交易日减少2.04%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163241a4535a39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163241a4535a39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01530","BK1593","HK0000165453.HKD","BK1583"],"gpt_icon":0},{"id":"2617683861","title":"3月6日美诺华涨8.41%，富安达医药创新混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2617683861","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617683861?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:23","pubTimestamp":1772785392,"startTime":"0","endTime":"0","summary":"证券之星消息，3月6日美诺华涨8.41%，收盘报22.31元，换手率7.17%，成交量15.49万手，成交额3.43亿元。重仓美诺华的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为富安达基金的富安达医药创新混合A。富安达医药创新混合A目前规模为0.8亿元，最新净值0.5545，较上一交易日上涨1.09%，近一年上涨2.88%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600025657.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239","BK1161","BK1574","159938","BK1515","09939"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0328},{"period":"1month","weight":-0.0406},{"period":"3month","weight":-0.0126},{"period":"6month","weight":0.0133},{"period":"1year","weight":0.0569},{"period":"ytd","weight":0.0049}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"name":"BK1161","nameEN":"BK1161"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物科技(BK1161)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物科技(BK1161)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物科技,BK1161,生物科技股票,生物科技股票老虎,生物科技股票老虎国际,生物科技行情,生物科技股票行情,生物科技股价,生物科技股市,生物科技股票价格,生物科技股票交易,生物科技股票购买,生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物科技(BK1161)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物科技(BK1161)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}